Fourth Quarter Momentum Carries over to January
It’s a new year, a new decade, and not much has changed in healthcare mergers and acquisitions. January was a strong month for deal flow, which isn’t unusual because deals that didn’t close in December often spill over into the following month, which just happens to launch a new fiscal cycle, for many entities. January 2020 opened with a strong showing for deal volume. At this writing, 132 deal are in our database and we’ll be adding more as earnings reports and other documents come to light. Looking back at December, we now have 168 deals on the books, as more Long-Term Care, Physician Medical Group and other transactions came to light. So the fourth quarter of 2019 finished in grand... Read More »
Health Care M&A Deals, Week Ending January 31, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price AstraZeneca plc Global rights to brazikumab N/A Home Health Care & Hospice Acquirer Target Price Eden Health Legacy Home Healthcare N/A Pharmaceuticals Acquirer Target Price Nestle SA Zenpep and Viokace N/A Atnahs Pharma Rights to hypertension... Read More »
Health Care M&A Deals, Week Ending January 17, 2020
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Incyte Corporation License to tafasitamab $750,000,000 Biogen Inc. PF-05251749 $75,000,000 BioNTech AG Neon Therapeutics, Inc. $67,000,000 Axsome Therapeutics, Inc. License to clinical data and AXS-14 $11,000,000 eHealth Acquirer... Read More »
Last-Minute Closings Made for a Busy December
December’s deal volume proved to be a fitting end to a busy year. With 148 deals already reported, the last month of the year easily topped November’s total of 136 (+9%) and even December 2018’s 142 deals (+4%). Deal makers were in a rush to close transactions by the end of the year, obviously. The services sectors benefited the most from this holiday rush, accounting for an unusually high 75% of December’s volume. By contrast, the services side contributed 68% of November’s deal volume and 69% of December 2018’s total. The average share is around 63% over the course of a year A few of the services sectors posted strong gains, year over year. Home Health & Hospice gained 100%, albeit... Read More »
Fourth Quarter 2019 Health Care Results Were Strong
Fourth quarter 2019 results will turn out to be a strong one. Deals are still being added, but the current total for Q4:19 is 430 transactions. That’s down about 6% compared with the third quarter’s 456 deals and 15% behind the same quarter in 2018, when 504 deals were announced. Some trends emerged in the quarter that bear out what we’re hearing from sources. Deal flow in the Behavioral Health Care sector softened in the fourth quarter, although it didn’t fall into negative territory. This sector has seen years of growth as private equity firms have piled in to build national and regional platforms around addiction treatment and autism programs and services. Autism is still the hottest... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
